SIRT1 and breast carcinoma: After treatments with NSAIDs and exisulind (Fig. 3b), the basal acetylation remained unchanged firmly demonstrating the direct role of SIRT1 in mediating the K382 acetylation induced by these compounds in breast cancer cells.